Related Experiment Video
Updated: Mar 24, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Transcription factor CCAAT/enhancer binding protein alpha up-regulates microRNA let-7a-1 in lung cancer cells by
Yani Lin1, Jian Zhao2, Xiaoyan Hu1
1Department of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan, 250012 People's Republic of China.
Aims:
The transcription factor CCAAT/enhancer binding protein α (C/EBPα) and microRNA (miRNA) let-7a-1 act as tumor suppressors in many types of cancers including lung cancer. In the present study, we aim to investigate whether let-7a-1 is a novel important target of C/EBPα in lung cancer cells.
Methods:
The DNA sequence of the 2.1 kb let-7a-1 promoter was analyzed with MatInspector 4.1 (http://www.genomatix.de). Human lung cancer cell lines A549 and H1299, and human cervical cancer cell line Hela were used for transfection. Total RNA was extracted from cells using Trizol reagent and pri-let-7a-1 mRNA expression was measured using quantitative real-time polymerase chain reaction. Western blotting was performed to detect C/EBPα protein expression. To test whether C/EBP-α could up-regulate the expression level of let-7a at transcription level, dual-luciferase reporter gene assay was carried out. To determine whether C/EBPα could bind let-7a-1 promoter, electrophoretic mobility shift assay was employed. To further confirm the direct targeting let-7a-1 promoter by C/EBPα, chromatin immunoprecipitation was used.
Results:
Both C/EBPα and let-7a-1 were down-regulated in lung cancer A549 and H1299 cells, but up-regulated in Hela cells. Transfection and reporter gene assay showed that C/EBPα increased the expression of let-7a-1 at transcription level. Bioinformatics assay identified four putative C/EBP elements within let-7a-1 promoter. Dual-luciferase reporter gene, electrophoretic mobility shift assay and chromatin immunoprecipitation assays demonstrated that these four elements mediated the up-regulation effect of C/EBPα on let-7a-1.
Conclusions:
The present study reveals that decreased C/EBPα contributes to the down-regulation of miRNA let-7a-1 in lung cancer cells.
Insights
CCAAT/enhancer binding protein α (C/EBPα) down-regulation in lung cancer cells leads to decreased microRNA let-7a-1 expression. This study identifies let-7a-1 as a direct transcriptional target of C/EBPα in lung cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- CCAAT/enhancer binding protein α (C/EBPα) and microRNA (miRNA) let-7a-1 are known tumor suppressors in various cancers, including lung cancer.
- Dysregulation of C/EBPα and let-7a-1 is observed in lung cancer cells.
Purpose of the Study:
- To investigate if let-7a-1 is a novel target of C/EBPα in lung cancer cells.
- To elucidate the regulatory relationship between C/EBPα and let-7a-1 in lung cancer.
Main Methods:
- Bioinformatic analysis of the let-7a-1 promoter for C/EBP binding sites.
- Quantitative real-time PCR and Western blotting to assess gene and protein expression.
- Dual-luciferase reporter gene assays to confirm transcriptional regulation.
- Electrophoretic mobility shift assays and chromatin immunoprecipitation to validate C/EBPα binding to the let-7a-1 promoter.
Main Results:
- C/EBPα and let-7a-1 were found to be downregulated in human lung cancer cell lines (A549, H1299).
- C/EBPα was shown to increase let-7a-1 expression at the transcriptional level.
- Four C/EBP binding elements in the let-7a-1 promoter were identified and confirmed to mediate C/EBPα's regulatory effect.
Conclusions:
- Decreased levels of C/EBPα contribute to the downregulation of miRNA let-7a-1 in lung cancer cells.
- let-7a-1 is a direct transcriptional target of C/EBPα, and this interaction is disrupted in lung cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Master Transcription Regulators
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

